新辅助化疗联合保乳手术治疗中晚期乳腺癌的临床应用价值

目的：探讨新辅助化疗联合保乳手术治疗中晚期乳腺癌的临床疗效。方法：回顾笔者所在医院近年来收治的62例中晚期乳腺癌患者的临床资料,分析新辅助化疗及保乳手术的临床疗效、美容效果及预后。结果：经新辅助化疗治疗后有19例患者符合保乳手术治疗指征,均行保乳手术治疗。术后随访6个月~3年,仅有2例发生肝转移,无乳腺癌复发及死亡病例。结论：术前应用新辅助化疗能有效降低乳腺癌分期,达到保乳手术治疗标准,且术后疗效满意,美容效果好,值得临床推广应用。

Clinical Vaiue of Mid-advanced Breast Cancer Treating with Neoadjuvant Chemotherapy Combined with Breast-conserving Surgery

Objective：To investigate the clinical curative effect of mid-advanced breast cancer treating with neoadjuvant chemotherapy combined with breast-conserving surgery.Method：Retrospective analyse the clinical information of 62 cases mid-advanced breast cancer patients treating with preoperative neoadjuvant chemotherapy in author＇s hospital, to analyse the clinical curative effect, beauty effect and prognosis. Result：After the neoadjuvant chemotherapy, 19 cases had the indicatio curativa of breast-conserving surgery, and all treated with breast-conserving surgery.Follow-up visit 6 months-3 years after the operation, there was no recidivation and died case, and only 2 case appeared hepatic metastases. Conclusion：Preoperative ncoadjuvant chemotherapy can reduce the degree of breast cancer, and achieve the breast surgery treatment standards, the clinical curative effect is satisfied, and worthy of clinical application.